Big pharma companies explain why tariffs will harm US investments
The first wave of biopharma comments on industry-specific tariffs is here. As of Thursday morning, just over 300 of at least 950 public comments have been released by the Department of Commerce in relation to ...
The first wave of biopharma comments on industry-specific tariffs is here.
As of Thursday morning, just over 300 of at least 950 public comments have been released by the Department of Commerce in relation to ...
